Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH
Study description
The purpose of the present study is to assess the effects of LMB763 with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH
Pathology
Non-alcoholic Statohepatitis NASH
Study type
Clinical trial
Status
Active
Study start date
2017
Funder Type
Industry funded study
Investigator
Dr.ssa med. Benedetta TERZIROLI BERETTA-PICCOLI
Recruitment
Completed